Ildong Pharmaceutical Co., Ltd. (249420.KS) KSC

21,800.00

+1200(+5.83%)

Updated at October 24 03:30PM

Currency In KRW

Valuation

Market Cap328.76B
Enterprise Value462.04B
P/E Ratio-157.13
PEG Ratio-18.24
Price/Sales Ratio1.17
Price/Book Ratio3.73
Enterprise/Revenue1.43
Enterprise/EBITDA10.88

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin-0.01
Operating Margin0.03

Management Effectiveness

Return On Assets-0.01
Return On Equity-0.02

Income Statement

Revenue614.94B
Revenue/Share20,984.86
Gross Profit233.46B
EBITDA33.59B
Net Income-4.58B
Diluted EPS-163.63

Balance Sheet

Total Cash68.54B
Total Cash/Share2,453.94
Total Debt208.09B
Total Debt/Equity1.28
Current Ratio0.77
Book Value Per Share5,735.85

Price History

52-Week Change59.24
52-Week High34,700
52-Week Low10,300
Moving Average 50 Days24,525
Moving Average 200 Days16,075

Statistics

Average Volume2.27M
Shares Outstanding31.51M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor21:20
Last Split DateMarch 05, 2020